Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Selective decontamination in bone marrow transplant recipients.

H F Guiot1, R van Furth

  • 1Department of Infectious Diseases, University Hospital, Leiden, The Netherlands.

Epidemiology and Infection
|December 1, 1992
PubMed
Summary

Selective decontamination (SD) prevents serious infections in bone marrow transplant patients. This strategy uses antibiotics to eliminate harmful bacteria and fungi while preserving beneficial gut flora, reducing infection risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transforming growth factor-beta suppresses interferon-gamma-induced toxoplasmastatic activity in murine macrophages by inhibition of tumour necrosis factor-alpha production.

Parasite immunology·2001
Same author

Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens.

Vaccine·2001
Same author

Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults.

Vaccine·2000
Same author

Interleukin-10 has different effects on proliferation of Listeria monocytogenes in livers and spleens of mice.

Infection and immunity·2000
Same author

Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study.

Vaccine·2000
Same author

Binding of murine antibodies against whole-cell pertussis vaccine or filamentous haemagglutinin by Bordetella pertussis from patients with whooping cough.

Scandinavian journal of immunology·2000

Area of Science:

  • Infectious Diseases
  • Hematology
  • Pharmacology

Background:

  • Bone marrow transplant patients experience profound immunocompromise due to conditioning regimens.
  • Deep granulocytopenia increases susceptibility to severe bacterial and fungal infections.
  • Selective decontamination (SD) is a strategy developed over 15 years to prevent these infections.

Purpose of the Study:

  • To describe the strategy of selective decontamination (SD) for preventing infections in immunocompromised patients undergoing bone marrow transplantation.
  • To detail the antibiotic regimens and their application in SD and systemic prophylaxis.
  • To report on the efficacy and remaining challenges of this approach.

Main Methods:

  • Standard SD involves oral antibiotics (neomycin, polymyxin B, pipemidic acid, amphotericin B) and local agents to eliminate aerobic Gram-negative rods, Staphylococcus aureus, and Candida spp.

Related Experiment Videos

  • Systemic penicillin is administered intravenously to prevent streptococcal infections.
  • Alternative antibiotics like ciprofloxacin and cotrimoxazole are used selectively for persistent infections or when oral administration is not possible.
  • Main Results:

    • The combination of SD and systemic prophylaxis effectively reduces major infections.
    • The majority of anaerobic flora are preserved, supporting colonization resistance.
    • The primary remaining issue is mild catheter-associated infections caused by coagulase-negative staphylococci.

    Conclusions:

    • Selective decontamination combined with systemic prophylaxis is an adequate strategy for infection prevention in bone marrow transplant recipients.
    • This approach successfully targets key pathogens while maintaining gut barrier function.
    • Further management strategies may be needed for catheter-related infections.